Literature DB >> 29521632

Overexpression of cytotoxic proteins correlates with liver function impairment in patients with drug reaction with eosinophilia and systemic symptoms (DRESS).

Fanping Yang1, Sheng-An Chen1, Xiaojin Wu1, Qinyuan Zhu1, Xiaoqun Luo1.   

Abstract

Drug reaction with eosinophilia and systemic symptoms (DRESS) is characterised by skin rash and multivisceral involvement. The liver is the organ most frequently affected and the degree of liver function impairment often correlates with the mortality rate of DRESS. We aimed to examine the expression of cytotoxic proteins, including soluble Fas ligand (sFasL), TNF-α, granulysin, perforin, and granzyme B in the sera and skin lesions of patients with DRESS and evaluate their clinical significance. Our cohort consisted of 21 patients with DRESS and control groups including 39 patients with Stevens-Johnson syndrome/toxic epidermal necrolysis, 21 patients with maculopapular eruption, and 29 normal controls. Concentrations of cytotoxic proteins in the sera were measured using enzyme-linked immunosorbent assays. Tissue samples were also obtained from typical skin lesions, and immunohistochemical staining was conducted to assess the local expression of cytotoxic proteins. We found that sFasL and granzyme B were significantly overexpressed in the sera of DRESS patients compared to normal controls. Furthermore, the levels of sFasL, perforin, and granzyme B significantly correlated with the serum level of liver enzymes in DRESS patients. Immunohistochemical examination also showed overexpressed cytotoxic proteins in cutaneous DRESS lesions. Cytotoxic proteins may play a vital role in the pathogenesis of DRESS, and serum sFasL, perforin, and granzyme B may also be involved in liver function impairment in DRESS patients.

Entities:  

Keywords:  cytotoxic protein; drug reaction with eosinophilia and systemic symptoms (DRESS); liver function impairment

Mesh:

Substances:

Year:  2018        PMID: 29521632     DOI: 10.1684/ejd.2017.3211

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  4 in total

Review 1.  Granulysin: killer lymphocyte safeguard against microbes.

Authors:  Farokh Dotiwala; Judy Lieberman
Journal:  Curr Opin Immunol       Date:  2019-05-18       Impact factor: 7.486

2.  The Role of In Vitro Detection of Drug-Specific Mediator-Releasing Cells to Diagnose Different Phenotypes of Severe Cutaneous Adverse Reactions.

Authors:  Jettanong Klaewsongkram; Supranee Buranapraditkun; Pattarawat Thantiworasit; Pawinee Rerknimitr; Papapit Tuchinda; Leena Chularojanamontri; Ticha Rerkpattanapipat; Kumutnart Chanprapaph; Wareeporn Disphanurat; Panlop Chakkavittumrong; Napatra Tovanabutra; Chutika Srisuttiyakorn; Yuttana Srinoulprasert; Chonlaphat Sukasem; Yuda Chongpison
Journal:  Allergy Asthma Immunol Res       Date:  2021-11       Impact factor: 5.764

3.  Serum immune modulators during the first cycle of anti-PD-1 antibody therapy in non-small cell lung cancer: Perforin as a biomarker.

Authors:  Takayo Ota; Tomoya Fukui; Yoshiro Nakahara; Takayuki Takeda; Junji Uchino; Takako Mouri; Keita Kudo; Saki Nakajima; Tomohiro Suzumura; Masahiro Fukuoka
Journal:  Thorac Cancer       Date:  2020-09-11       Impact factor: 3.500

4.  Cutaneous and systemic hyperinflammation drives maculopapular drug exanthema in severely ill COVID-19 patients.

Authors:  Yasutaka Mitamura; Daniel Schulz; Saskia Oro; Nick Li; Isabel Kolm; Claudia Lang; Reihane Ziadlou; Ge Tan; Bernd Bodenmiller; Peter Steiger; Angelo Marzano; Nicolas de Prost; Olivier Caudin; Mitchell Levesque; Corinne Stoffel; Peter Schmid-Grendelmeier; Emanual Maverakis; Cezmi A Akdis; Marie-Charlotte Brüggen
Journal:  Allergy       Date:  2021-07-19       Impact factor: 14.710

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.